CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: methyl phenyl(piperidin-2-yl)acetate
Accession: CHEBI:84276
browse the term
Definition: A amino acid ester that is methyl phenylacetate in which one of the hydrogens alpha to the carbonyl group is replaced by a piperidin-2-yl group.
Synonyms: related_synonym: Formula=C14H19NO2; InChI=1S/C14H19NO2/c1-17-14(16)13(11-7-3-2-4-8-11)12-9-5-6-10-15-12/h2-4,7-8,12-13,15H,5-6,9-10H2,1H3; InChIKey=DUGOZIWVEXMGBE-UHFFFAOYSA-N; SMILES=COC(=O)C(C1CCCCN1)c1ccccc1; alpha-phenyl-2-piperidineacetic acid methyl ester; methyl alpha-phenyl-alpha-(2-piperidyl)acetate; methyl alpha-phenyl-alpha-2-piperidinylacetate; methyl phenidylacetate; methylphenidan
G
Akr1b1
aldo-keto reductase family 1 member B
decreases expression
ISO
Methylphenidate results in decreased expression of AKR1B3 mRNA
CTD
PMID:22470460
NCBI chr 4:61,706,866...61,720,959
Ensembl chr 4:61,706,864...61,720,956
G
Ap2b1
adaptor related protein complex 2 subunit beta 1
increases expression
ISO
Methylphenidate results in increased expression of AP2B1 mRNA
CTD
PMID:22470460
NCBI chr10:70,516,462...70,621,973
Ensembl chr10:70,520,206...70,621,977
G
Arap1
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1
decreases expression
ISO
Methylphenidate results in decreased expression of ARAP1 mRNA
CTD
PMID:22470460
NCBI chr 1:166,459,062...166,525,200
Ensembl chr 1:166,478,005...166,525,255
G
Arc
activity-regulated cytoskeleton-associated protein
affects expression
EXP
Methylphenidate affects the expression of ARC mRNA
CTD
PMID:19222557
NCBI chr 7:115,907,097...115,911,059
Ensembl chr 7:115,907,097...115,910,541
G
Arih2
ariadne RBR E3 ubiquitin protein ligase 2
decreases expression
ISO
Methylphenidate results in decreased expression of ARIH2 mRNA
CTD
PMID:22470460
NCBI chr 8:117,387,004...117,446,085
Ensembl chr 8:117,387,010...117,446,019
G
Armc9
armadillo repeat containing 9
decreases expression
ISO
Methylphenidate results in decreased expression of ARMC9 mRNA
CTD
PMID:22470460
NCBI chr 9:93,172,718...93,299,119
Ensembl chr 9:93,172,673...93,296,750
G
B4galt4
beta-1,4-galactosyltransferase 4
decreases expression
ISO
Methylphenidate results in decreased expression of B4GALT4 mRNA
CTD
PMID:22470460
NCBI chr11:64,558,006...64,584,054
Ensembl chr11:64,557,977...64,583,994
G
Bcl9
BCL9, transcription coactivator
decreases expression
ISO
Methylphenidate results in decreased expression of BCL9 mRNA
CTD
PMID:22470460
NCBI chr 2:199,334,644...199,420,083
Ensembl chr 2:199,334,664...199,354,793
G
Bdnf
brain-derived neurotrophic factor
affects expression multiple interactions decreases expression
EXP ISO
Methylphenidate affects the expression of BDNF mRNA [staurosporine aglycone binds to and results in decreased activity of NTRK2 protein] inhibits the reaction [Methylphenidate inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased expression of BDNF protein]]; Methylphenidate inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased expression of BDNF protein] Methylphenidate results in decreased expression of BDNF mRNA
CTD
PMID:19222557 PMID:22470460 PMID:24394491
NCBI chr 3:100,768,637...100,819,216
Ensembl chr 3:100,768,637...100,819,210
G
C2
complement C2
increases expression
ISO
Methylphenidate results in increased expression of C2 mRNA
CTD
PMID:22470460
NCBI chr20:4,542,340...4,561,152
Ensembl chr20:4,542,340...4,561,152
G
Cald1
caldesmon 1
increases expression
ISO
Methylphenidate results in increased expression of CALD1 mRNA
CTD
PMID:22470460
NCBI chr 4:62,103,948...62,291,375
Ensembl chr 4:62,220,736...62,291,489
G
Cbr3
carbonyl reductase 3
increases expression
ISO
Methylphenidate results in increased expression of CBR3 mRNA
CTD
PMID:22470460
NCBI chr11:33,909,417...33,917,674
Ensembl chr11:33,909,439...33,917,674
G
Ccdc166
coiled-coil domain containing 166
decreases expression
ISO
Methylphenidate results in decreased expression of CCDC166 mRNA
CTD
PMID:22470460
NCBI chr 7:117,039,890...117,041,693
Ensembl chr 7:117,039,892...117,041,693
G
Ccdc91
coiled-coil domain containing 91
decreases expression
ISO
Methylphenidate results in decreased expression of CCDC91 mRNA
CTD
PMID:22470460
NCBI chr 4:181,873,465...182,043,593
Ensembl chr 4:181,874,861...182,043,593
G
Cdk5r1
cyclin-dependent kinase 5 regulatory subunit 1
increases expression
ISO
Methylphenidate results in increased expression of CDK5R1 mRNA
CTD
PMID:22470460
NCBI chr10:67,862,054...67,863,255
Ensembl chr10:67,862,054...67,863,255
G
Ces1d
carboxylesterase 1D
multiple interactions increases hydrolysis increases metabolic processing
ISO
[CES1 protein results in increased hydrolysis of Methylphenidate] which results in increased chemical synthesis of ritalinic acid; Aripiprazole inhibits the reaction [CES1 protein results in increased hydrolysis of Methylphenidate]; CES1 gene mutant form results in decreased metabolism of and results in increased abundance of Methylphenidate; Fluoxetine inhibits the reaction [CES1 protein results in increased hydrolysis of Methylphenidate]; Perphenazine inhibits the reaction [CES1 protein results in increased hydrolysis of Methylphenidate]; Thioridazine inhibits the reaction [CES1 protein results in increased hydrolysis of Methylphenidate] aripiprazole inhibits the reaction [CES1 protein results in increased hydrolysis of Methylphenidate] CES1 protein results in increased metabolism of Methylphenidate
CTD
PMID:15082749 PMID:18485328 PMID:20097249 PMID:25445008
NCBI chr19:15,195,514...15,239,827
Ensembl chr19:15,033,108...15,239,821
G
Chd2
chromodomain helicase DNA binding protein 2
increases expression
ISO
Methylphenidate results in increased expression of CHD2 mRNA
CTD
PMID:22470460
NCBI chr 1:134,757,934...134,873,053
Ensembl chr 1:134,757,934...134,871,167
G
Chga
chromogranin A
decreases expression
ISO
Methylphenidate results in decreased expression of CHGA mRNA
CTD
PMID:22470460
NCBI chr 6:126,434,226...126,445,569
Ensembl chr 6:126,434,226...126,445,568
G
Chid1
chitinase domain containing 1
decreases expression
ISO
Methylphenidate results in decreased expression of CHID1 mRNA
CTD
PMID:22470460
NCBI chr 1:214,476,418...214,511,569
Ensembl chr 1:214,476,387...214,511,529
G
Chrna6
cholinergic receptor nicotinic alpha 6 subunit
decreases expression
ISO
Methylphenidate results in decreased expression of CHRNA6 mRNA
CTD
PMID:22470460
NCBI chr16:68,860,018...68,866,718
Ensembl chr16:68,860,018...68,866,718
G
Chst8
carbohydrate sulfotransferase 8
decreases expression
ISO
Methylphenidate results in decreased expression of CHST8 mRNA
CTD
PMID:22470460
NCBI chr 1:90,542,095...90,685,257
Ensembl chr 1:90,542,096...90,685,257
G
Clpx
caseinolytic mitochondrial matrix peptidase chaperone subunit X
increases expression
ISO
Methylphenidate results in increased expression of CLPX mRNA
CTD
PMID:22470460
NCBI chr 8:70,789,137...70,843,133
Ensembl chr 8:70,789,256...70,843,123
G
Cnnm1
cyclin and CBS domain divalent metal cation transport mediator 1
increases expression
ISO
Methylphenidate results in increased expression of CNNM1 mRNA
CTD
PMID:22470460
NCBI chr 1:263,184,361...263,243,912
Ensembl chr 1:263,186,235...263,242,468
G
Cnot6l
CCR4-NOT transcription complex, subunit 6-like
decreases expression
ISO
Methylphenidate results in decreased expression of CNOT6L mRNA
CTD
PMID:22470460
NCBI chr14:15,059,101...15,148,255
Ensembl chr14:15,059,387...15,146,586
G
Cnr1
cannabinoid receptor 1
increases expression
ISO
Methylphenidate results in increased expression of CNR1 mRNA
CTD
PMID:22470460
NCBI chr 5:49,307,584...49,333,064
Ensembl chr 5:49,311,030...49,333,056
G
Comtd1
catechol-O-methyltransferase domain containing 1
decreases expression
ISO
Methylphenidate results in decreased expression of COMTD1 mRNA
CTD
PMID:22470460
NCBI chr15:2,631,529...2,634,640
Ensembl chr15:2,631,529...2,634,640
G
Creb1
cAMP responsive element binding protein 1
multiple interactions decreases expression
EXP
[Fluoxetine co-treated with Methylphenidate] results in increased expression of CREB mRNA; [Fluoxetine co-treated with Methylphenidate] results in increased phosphorylation of CREB protein Methylphenidate results in decreased expression of CREB mRNA
CTD
PMID:21753012
NCBI chr 9:71,229,753...71,298,994
Ensembl chr 9:71,230,108...71,293,435
G
D2hgdh
D-2-hydroxyglutarate dehydrogenase
decreases expression
ISO
Methylphenidate results in decreased expression of D2HGDH mRNA
CTD
PMID:22470460
NCBI chr 9:100,956,570...100,974,393
Ensembl chr 9:100,956,477...100,974,551
G
Dapk3
death-associated protein kinase 3
decreases expression
ISO
Methylphenidate results in decreased expression of DAPK3 mRNA
CTD
PMID:22470460
NCBI chr 7:11,392,436...11,400,855
Ensembl chr 7:11,392,437...11,400,805
G
Dhx35
DEAH-box helicase 35
decreases expression
ISO
Methylphenidate results in decreased expression of DHX35 mRNA
CTD
PMID:22470460
NCBI chr 3:155,297,545...155,354,857
Ensembl chr 3:155,297,566...155,356,462
G
Drd1
dopamine receptor D1
multiple interactions
EXP
[SCH 23390 binds to and results in decreased activity of DRD1 protein] which results in decreased susceptibility to Methylphenidate
CTD
PMID:11454915
NCBI chr17:11,099,736...11,104,352
Ensembl chr17:11,101,306...11,103,541
G
Drd2
dopamine receptor D2
multiple interactions decreases expression affects expression
EXP ISO
[Raclopride binds to and results in decreased activity of DRD2 protein] which results in decreased susceptibility to Methylphenidate Methylphenidate results in decreased expression of DRD2 mRNA Methylphenidate affects the expression of DRD2 protein
CTD
PMID:11454915 PMID:17599397 PMID:22470460
NCBI chr 8:53,678,777...53,743,643
Ensembl chr 8:53,678,777...53,743,642
G
Drd4
dopamine receptor D4
affects response to substance
ISO
DRD4 promoter mutant form affects the susceptibility to Methylphenidate
CTD
PMID:17023870
NCBI chr 1:214,278,296...214,282,818
Ensembl chr 1:214,278,296...214,281,483
G
Egr1
early growth response 1
multiple interactions increases expression
EXP
[Fluoxetine co-treated with Methylphenidate] results in increased expression of EGR1 mRNA; Fluoxetine promotes the reaction [Methylphenidate results in increased expression of EGR1 mRNA]; Methylphenidate promotes the reaction [Amphetamine results in increased expression of EGR1 mRNA]; SCH 23390 inhibits the reaction [Methylphenidate results in increased expression of EGR1 mRNA]
CTD
PMID:16549270 PMID:19931852 PMID:20020108 PMID:21753012
NCBI chr18:27,657,903...27,660,101
Ensembl chr18:27,657,628...27,661,429
G
Entpd5
ectonucleoside triphosphate diphosphohydrolase 5
decreases expression
ISO
Methylphenidate results in decreased expression of ENTPD5 mRNA
CTD
PMID:22470460
NCBI chr 6:108,087,677...108,123,811
Ensembl chr 6:108,087,418...108,120,579
G
Epb41l1
erythrocyte membrane protein band 4.1-like 1
decreases expression
ISO
Methylphenidate results in decreased expression of EPB41L1 mRNA
CTD
PMID:22470460
NCBI chr 3:152,492,725...152,622,047
Ensembl chr 3:152,552,822...152,619,722
G
Epha10
EPH receptor A10
decreases expression
ISO
Methylphenidate results in decreased expression of EPHA10 mRNA
CTD
PMID:22470460
NCBI chr 5:142,875,171...142,910,537
Ensembl chr 5:142,875,773...142,908,395
G
Exog
exo/endonuclease G
decreases expression
ISO
Methylphenidate results in decreased expression of EXOG mRNA
CTD
PMID:22470460
NCBI chr 8:128,133,398...128,153,110
Ensembl chr 8:128,133,431...128,153,110
G
Fank1
fibronectin type III and ankyrin repeat domains 1
decreases expression
ISO
Methylphenidate results in decreased expression of FANK1 mRNA
CTD
PMID:22470460
NCBI chr 1:205,842,469...205,954,152
Ensembl chr 1:205,842,489...205,950,371
G
Fcgr2b
Fc fragment of IgG receptor IIb
increases expression
ISO
Methylphenidate results in increased expression of FCGR2B mRNA
CTD
PMID:22470460
NCBI chr13:89,329,298...89,343,916
Ensembl chr13:89,327,794...89,433,815
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
multiple interactions increases expression decreases expression
ISO EXP
[Methylphenidate co-treated with SLC6A3 protein] results in increased expression of FOS protein; Methylphenidate inhibits the reaction [[Dopamine co-treated with SLC6A3 protein] results in increased expression of FOS mRNA]; Methylphenidate inhibits the reaction [[Dopamine co-treated with SLC6A3 protein] results in increased expression of FOS protein] Methylphenidate results in increased expression of FOS mRNA [Fluoxetine co-treated with Methylphenidate] results in increased expression of FOS mRNA; Fluoxetine promotes the reaction [Methylphenidate results in increased expression of FOS mRNA] Methylphenidate results in increased expression of FOS protein Methylphenidate results in decreased expression of FOS protein SLC6A3 protein affects the reaction [Methylphenidate results in increased expression of FOS protein] Methylphenidate results in increased expression of FOS mRNA; Methylphenidate results in increased expression of FOS protein
CTD
PMID:12112414 PMID:12699766 PMID:15916815 PMID:19931852 PMID:21753012
NCBI chr 6:109,300,433...109,303,299
Ensembl chr 6:109,300,433...109,303,299
G
Fosb
FosB proto-oncogene, AP-1 transcription factor subunit
increases expression
EXP
Methylphenidate results in increased expression of FOSB protein
CTD
PMID:15916815
NCBI chr 1:80,214,691...80,221,417
Ensembl chr 1:80,214,494...80,221,710
G
Galnt10
polypeptide N-acetylgalactosaminyltransferase 10
decreases expression
ISO
Methylphenidate results in decreased expression of GALNT10 mRNA
CTD
PMID:22470460
NCBI chr10:43,067,316...43,208,992
Ensembl chr10:43,067,299...43,210,427
G
Gch1
GTP cyclohydrolase 1
decreases expression
ISO
Methylphenidate results in decreased expression of GCH1 mRNA
CTD
PMID:22470460
NCBI chr15:23,935,011...23,968,971
Ensembl chr15:23,934,585...23,969,011
G
Gdnf
glial cell derived neurotrophic factor
decreases expression
ISO
Methylphenidate results in decreased expression of GDNF mRNA
CTD
PMID:22470460
NCBI chr 2:56,884,181...56,912,964
Ensembl chr 2:56,887,987...56,910,238
G
Ghdc
GH3 domain containing
decreases expression
ISO
Methylphenidate results in decreased expression of GHDC mRNA
CTD
PMID:22470460
NCBI chr10:88,672,834...88,677,055
Ensembl chr10:88,672,843...88,677,055
G
Grik3
glutamate ionotropic receptor kainate type subunit 3
decreases expression
ISO
Methylphenidate results in decreased expression of GRIK3 mRNA
CTD
PMID:22470460
NCBI chr 5:143,500,441...143,715,546
Ensembl chr 5:143,500,441...143,715,546
G
Gucy2c
guanylate cyclase 2C
decreases expression
ISO
Methylphenidate results in decreased expression of GUCY2C mRNA
CTD
PMID:22470460
NCBI chr 4:170,659,993...170,740,274
Ensembl chr 4:170,659,998...170,740,274
G
Hbp1
HMG-box transcription factor 1
decreases expression
ISO
Methylphenidate results in decreased expression of HBP1 mRNA
CTD
PMID:22470460
NCBI chr 6:51,231,479...51,257,699
Ensembl chr 6:51,231,480...51,257,625
G
Homer1
homer scaffold protein 1
increases expression multiple interactions
EXP
Methylphenidate results in increased expression of HOMER1 mRNA SCH 23390 inhibits the reaction [Methylphenidate results in increased expression of HOMER1 mRNA]
CTD
PMID:16549270
NCBI chr 2:22,909,550...23,012,303
Ensembl chr 2:22,909,569...23,009,678
G
Hspb6
heat shock protein family B (small) member 6
decreases expression
ISO
Methylphenidate results in decreased expression of HSPB6 mRNA
CTD
PMID:22470460
NCBI chr 1:89,008,117...89,010,256
Ensembl chr 1:89,008,117...89,010,256
G
Il6
interleukin 6
increases expression
ISO
Methylphenidate results in increased expression of IL6 mRNA
CTD
PMID:22470460
NCBI chr 4:3,043,231...3,047,807
Ensembl chr 4:3,043,231...3,047,807
G
Ip6k1
inositol hexakisphosphate kinase 1
increases expression
ISO
Methylphenidate results in increased expression of IP6K1 mRNA
CTD
PMID:22470460
NCBI chr 8:116,781,957...116,826,152
Ensembl chr 8:116,804,451...116,823,540
G
Jak3
Janus kinase 3
decreases expression
ISO
Methylphenidate results in decreased expression of JAK3 mRNA
CTD
PMID:22470460
NCBI chr16:20,107,471...20,120,678
Ensembl chr16:20,109,200...20,120,668
G
Kifc3
kinesin family member C3
decreases expression
ISO
Methylphenidate results in decreased expression of KIFC3 mRNA
CTD
PMID:22470460
NCBI chr19:10,305,405...10,339,186
Ensembl chr19:10,320,604...10,339,178
G
Lad1
ladinin 1
decreases expression
ISO
Methylphenidate results in decreased expression of LAD1 mRNA
CTD
PMID:22470460
NCBI chr13:52,645,257...52,659,619
Ensembl chr13:52,645,257...52,659,619
G
Lama3
laminin subunit alpha 3
decreases expression
ISO
Methylphenidate results in decreased expression of LAMA3 mRNA
CTD
PMID:22470460
NCBI chr18:3,704,866...3,941,215
Ensembl chr18:3,705,916...3,940,838
G
Large1
LARGE xylosyl- and glucuronyltransferase 1
decreases expression
ISO
Methylphenidate results in decreased expression of LARGE1 mRNA
CTD
PMID:22470460
NCBI chr19:12,481,563...12,945,320
Ensembl chr19:12,481,540...12,942,963
G
Lasp1
LIM and SH3 protein 1
increases expression
ISO
Methylphenidate results in increased expression of LASP1 mRNA
CTD
PMID:22470460
NCBI chr10:85,744,662...85,785,130
Ensembl chr10:85,744,568...85,785,133
G
Lgals3bp
galectin 3 binding protein
decreases expression
ISO
Methylphenidate results in decreased expression of LGALS3BP mRNA
CTD
PMID:22470460
NCBI chr10:107,415,334...107,424,672
Ensembl chr10:107,415,326...107,424,710
G
Lhfpl5
LHFPL tetraspan subfamily member 5
decreases expression
ISO
Methylphenidate results in decreased expression of LHFPL5 mRNA
CTD
PMID:22470460
NCBI chr20:5,815,837...5,826,137
Ensembl chr20:5,815,837...5,826,137
G
Lrrc27
leucine rich repeat containing 27
decreases expression
ISO
Methylphenidate results in decreased expression of LRRC27 mRNA
CTD
PMID:22470460
NCBI chr 1:211,543,751...211,575,823
Ensembl chr 1:211,543,751...211,575,820
G
Map1lc3b
microtubule-associated protein 1 light chain 3 beta
decreases expression
ISO
Methylphenidate results in decreased expression of MAP1LC3B mRNA
CTD
PMID:22470460
NCBI chr19:53,635,449...53,643,970
Ensembl chr19:53,629,779...53,646,058
G
Mapk1
mitogen activated protein kinase 1
decreases expression multiple interactions
EXP
Methylphenidate results in decreased expression of MAPK1 mRNA [Fluoxetine co-treated with Methylphenidate] results in increased expression of MAPK1 mRNA; [Fluoxetine co-treated with Methylphenidate] results in increased phosphorylation of MAPK1 protein
CTD
PMID:21753012
NCBI chr11:88,203,863...88,273,301
Ensembl chr11:88,211,599...88,273,254
G
Mapk8
mitogen-activated protein kinase 8
increases expression
ISO
Methylphenidate results in increased expression of MAPK8 mRNA
CTD
PMID:22470460
NCBI chr16:9,620,854...9,709,342
Ensembl chr16:9,625,177...9,709,347
G
Mlc1
modulator of VRAC current 1
decreases expression
ISO
Methylphenidate results in decreased expression of MLC1 mRNA
CTD
PMID:22470460
NCBI chr 7:129,949,984...129,970,314
Ensembl chr 7:129,949,967...129,970,550
G
Morn2
MORN repeat containing 2
decreases expression
ISO
Methylphenidate results in decreased expression of MORN2 mRNA
CTD
PMID:22470460
NCBI chr 6:2,969,290...2,974,419
Ensembl chr 6:2,969,333...2,974,418
G
Mtor
mechanistic target of rapamycin kinase
multiple interactions affects expression
EXP
[Fluoxetine co-treated with Methylphenidate] results in increased expression of MTOR mRNA; [Fluoxetine co-treated with Methylphenidate] results in increased phosphorylation of MTOR protein Methylphenidate affects the expression of MTOR mRNA
CTD
PMID:21753012
NCBI chr 5:165,263,813...165,373,967
Ensembl chr 5:165,263,800...165,373,967
G
Mvp
major vault protein
decreases expression
ISO
Methylphenidate results in decreased expression of MVP mRNA
CTD
PMID:22470460
NCBI chr 1:198,420,813...198,448,612
Ensembl chr 1:198,420,806...198,450,047
G
Nabp1
nucleic acid binding protein 1
increases expression
ISO
Methylphenidate results in increased expression of NABP1 mRNA
CTD
PMID:22470460
NCBI chr 9:55,049,893...55,057,784
Ensembl chr 9:55,050,203...55,057,658
G
Nacad
NAC alpha domain containing
decreases expression
ISO
Methylphenidate results in decreased expression of NACAD mRNA
CTD
PMID:22470460
NCBI chr14:86,860,607...86,868,605
Ensembl chr14:86,860,608...86,868,598
G
Ncor2
nuclear receptor co-repressor 2
decreases expression
ISO
Methylphenidate results in decreased expression of NCOR2 mRNA
CTD
PMID:22470460
NCBI chr12:36,871,917...37,033,701
Ensembl chr12:36,871,999...37,033,701
G
Neto2
neuropilin and tolloid like 2
increases expression
ISO
Methylphenidate results in increased expression of NETO2 mRNA
CTD
PMID:22470460
NCBI chr19:22,450,579...22,486,530
Ensembl chr19:22,450,030...22,486,531
G
Nol3
nucleolar protein 3
decreases expression
ISO
Methylphenidate results in decreased expression of NOL3 mRNA
CTD
PMID:22470460
NCBI chr19:37,232,567...37,236,668
Ensembl chr19:37,235,001...37,236,649
G
Nsun4
NOP2/Sun RNA methyltransferase 4
increases expression
ISO
Methylphenidate results in increased expression of NSUN4 mRNA
CTD
PMID:22470460
NCBI chr 5:134,885,377...134,905,492
Ensembl chr 5:134,886,497...134,905,588
G
Ntrk2
neurotrophic receptor tyrosine kinase 2
multiple interactions
ISO
[staurosporine aglycone binds to and results in decreased activity of NTRK2 protein] inhibits the reaction [Methylphenidate inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased expression of BDNF protein]]
CTD
PMID:24394491
NCBI chr17:5,934,651...6,245,778
Ensembl chr17:5,933,729...6,244,676
G
Parp3
poly (ADP-ribose) polymerase family, member 3
increases expression
ISO
Methylphenidate results in increased expression of PARP3 mRNA
CTD
PMID:22470460
NCBI chr 8:115,173,440...115,179,543
Ensembl chr 8:115,173,453...115,179,191
G
Pear1
platelet endothelial aggregation receptor 1
increases expression
ISO
Methylphenidate results in increased expression of PEAR1 mRNA
CTD
PMID:22470460
NCBI chr 2:187,114,219...187,134,209
Ensembl chr 2:187,114,217...187,133,993
G
Peds1
plasmanylethanolamine desaturase 1
decreases expression
ISO
Methylphenidate results in decreased expression of TMEM189 mRNA
CTD
PMID:22470460
NCBI chr 3:164,376,621...164,388,213
Ensembl chr 3:164,376,630...164,388,492
G
Pisd
phosphatidylserine decarboxylase
decreases expression
ISO
Methylphenidate results in decreased expression of PISD mRNA
CTD
PMID:22470460
NCBI chr14:83,298,630...83,347,697
Ensembl chr14:83,298,674...83,346,738
G
Pkn1
protein kinase N1
decreases expression
ISO
Methylphenidate results in decreased expression of PKN1 mRNA
CTD
PMID:22470460
NCBI chr19:24,803,524...24,832,305
Ensembl chr19:24,803,524...24,831,500
G
Pnma8b
PNMA family member 8B
increases expression
ISO
Methylphenidate results in increased expression of PNMAL2 mRNA
CTD
PMID:22470460
NCBI chr 1:78,876,205...78,878,779
Ensembl chr 1:78,876,205...78,878,779
G
Prkg2
protein kinase cGMP-dependent 2
increases expression
ISO
Methylphenidate results in increased expression of PRKG2 mRNA
CTD
PMID:22470460
NCBI chr14:12,217,121...12,313,616
Ensembl chr14:12,218,553...12,315,229
G
Prlr
prolactin receptor
decreases expression
ISO
Methylphenidate results in decreased expression of PRLR mRNA
CTD
PMID:22470460
NCBI chr 2:60,131,410...60,325,686
Ensembl chr 2:60,131,776...60,325,692
G
Prpf39
pre-mRNA processing factor 39
increases expression
ISO
Methylphenidate results in increased expression of PRPF39 mRNA
CTD
PMID:22470460
NCBI chr 6:86,785,793...86,810,806
Ensembl chr 6:86,785,771...86,810,316
G
Ptdss2
phosphatidylserine synthase 2
decreases expression
ISO
Methylphenidate results in decreased expression of PTDSS2 mRNA
CTD
PMID:22470460
NCBI chr 1:214,122,981...214,148,011
Ensembl chr 1:214,123,044...214,149,729
G
Ptpn21
protein tyrosine phosphatase, non-receptor type 21
increases expression
ISO
Methylphenidate results in increased expression of PTPN21 mRNA
CTD
PMID:22470460
NCBI chr 6:122,656,500...122,721,496
Ensembl chr 6:122,656,500...122,721,496
G
Pus7l
pseudouridine synthase 7 like
decreases expression
ISO
Methylphenidate results in decreased expression of PUS7L mRNA
CTD
PMID:22470460
NCBI chr 7:135,765,307...135,803,818
Ensembl chr 7:135,765,303...135,800,481
G
Rab38
RAB38, member RAS oncogene family
increases expression
ISO
Methylphenidate results in increased expression of RAB38 mRNA
CTD
PMID:22470460
NCBI chr 1:152,072,716...152,153,449
Ensembl chr 1:152,072,665...152,153,449
G
Racgap1
Rac GTPase-activating protein 1
decreases expression
ISO
Methylphenidate results in decreased expression of RACGAP1 mRNA
CTD
PMID:22470460
NCBI chr 7:141,277,303...141,308,849
Ensembl chr 7:141,277,312...141,307,233
G
Rbfox1
RNA binding fox-1 homolog 1
increases expression
ISO
Methylphenidate results in increased expression of RBFOX1 mRNA
CTD
PMID:22470460
NCBI chr10:8,312,961...10,437,778
Ensembl chr10:8,312,961...8,654,892
G
Rcc2
regulator of chromosome condensation 2
decreases expression
ISO
Methylphenidate results in decreased expression of RCC2 mRNA
CTD
PMID:22470460
NCBI chr 5:159,220,531...159,236,313
Ensembl chr 5:159,220,979...159,234,320
G
Ret
ret proto-oncogene
decreases expression
ISO
Methylphenidate results in decreased expression of RET mRNA
CTD
PMID:22470460
NCBI chr 4:150,202,170...150,249,196
Ensembl chr 4:150,202,058...150,244,372
G
Rgma
repulsive guidance molecule BMP co-receptor a
decreases expression
ISO
Methylphenidate results in decreased expression of RGMA mRNA
CTD
PMID:22470460
NCBI chr 1:134,699,053...134,742,512
Ensembl chr 1:134,699,299...134,742,514
G
Rgs20
regulator of G-protein signaling 20
decreases expression
ISO
Methylphenidate results in decreased expression of RGS20 mRNA
CTD
PMID:22470460
NCBI chr 5:14,367,498...14,494,048
Ensembl chr 5:14,415,606...14,494,756
G
Rhbdd2
rhomboid domain containing 2
decreases expression
ISO
Methylphenidate results in decreased expression of RHBDD2 mRNA
CTD
PMID:22470460
NCBI chr12:24,091,132...24,102,081
Ensembl chr12:24,092,004...24,102,084
G
Sdc3
syndecan 3
decreases expression
ISO
Methylphenidate results in decreased expression of SDC3 mRNA
CTD
PMID:22470460
NCBI chr 5:148,923,098...148,956,404
Ensembl chr 5:148,923,098...148,956,404
G
Siae
sialic acid acetylesterase
decreases expression
ISO
Methylphenidate results in decreased expression of SIAE mRNA
CTD
PMID:22470460
NCBI chr 8:40,078,269...40,113,514
Ensembl chr 8:40,078,269...40,113,514
G
Slc10a4
solute carrier family 10, member 4
decreases expression
ISO
Methylphenidate results in decreased expression of SLC10A4 mRNA
CTD
PMID:22470460
NCBI chr14:37,764,839...37,770,059
Ensembl chr14:37,764,839...37,770,059
G
Slc18a2
solute carrier family 18 member A2
decreases expression
ISO
Methylphenidate results in decreased expression of SLC18A2 mRNA
CTD
PMID:22470460
NCBI chr 1:280,397,831...280,457,968
Ensembl chr 1:280,423,079...280,457,148
G
Slc2a12
solute carrier family 2 member 12
increases expression
ISO
Methylphenidate results in increased expression of SLC2A12 mRNA
CTD
PMID:22470460
NCBI chr 1:24,003,625...24,056,373
Ensembl chr 1:24,003,625...24,056,373
G
Slc6a3
solute carrier family 6 member 3
multiple interactions decreases expression increases response to substance affects response to substance
ISO
[Methylphenidate co-treated with SLC6A3 protein] results in increased expression of FOS protein; [SLC6A3 protein polymorphism affects the susceptibility to Methylphenidate] which affects the uptake of Dopamine; Methylphenidate inhibits the reaction [[Dopamine co-treated with SLC6A3 protein] results in increased expression of FOS mRNA]; Methylphenidate inhibits the reaction [[Dopamine co-treated with SLC6A3 protein] results in increased expression of FOS protein]; Methylphenidate inhibits the reaction [SLC6A3 protein mutant form results in increased export of Dopamine]; Methylphenidate inhibits the reaction [SLC6A3 protein promotes the reaction [Dopamine results in increased activity of TAAR1 protein]]; Methylphenidate inhibits the reaction [SLC6A3 protein promotes the reaction [Methamphetamine results in increased activity of TAAR1 protein]]; Methylphenidate inhibits the reaction [SLC6A3 protein promotes the reaction [Octopamine results in increased activity of TAAR1 protein]]; Methylphenidate inhibits the reaction [SLC6A3 protein promotes the reaction [tryptamine results in increased activity of TAAR1 protein]]; Methylphenidate inhibits the reaction [SLC6A3 protein promotes the reaction [Tyramine results in increased activity of TAAR1 protein]]; Methylphenidate inhibits the reaction [SLC6A3 protein results in increased uptake of Dopamine] Methylphenidate results in decreased expression of SLC6A3 mRNA Methylphenidate results in decreased expression of SLC6A3 protein SLC6A3 protein results in increased susceptibility to Methylphenidate SLC6A3 protein affects the reaction [Methylphenidate results in increased expression of FOS protein] SLC6A3 3' UTR polymorphism affects the susceptibility to Methylphenidate; SLC6A3 protein polymorphism affects the susceptibility to Methylphenidate
CTD
PMID:12112414 PMID:12699766 PMID:15059031 PMID:16139732 PMID:17234900 PMID:18614672 PMID:19462300 PMID:22470460 PMID:31009648
NCBI chr 1:32,323,011...32,363,983
Ensembl chr 1:32,321,580...32,363,983
G
Snap25
synaptosome associated protein 25
affects response to substance
ISO
SNAP25 gene polymorphism affects the susceptibility to Methylphenidate
CTD
PMID:17023870
NCBI chr 3:129,697,408...129,788,417
Ensembl chr 3:129,599,353...129,788,400
G
Sncaip
synuclein, alpha interacting protein
increases expression
ISO
Methylphenidate results in increased expression of SNCAIP mRNA
CTD
PMID:22470460
NCBI chr18:47,739,284...47,877,679
Ensembl chr18:47,739,140...47,877,676
G
Sncg
synuclein, gamma
decreases expression
ISO
Methylphenidate results in decreased expression of SNCG mRNA
CTD
PMID:22470460
NCBI chr16:10,722,110...10,726,648
Ensembl chr16:10,722,106...10,726,707
G
Snx22
sorting nexin 22
decreases expression
ISO
Methylphenidate results in decreased expression of SNX22 mRNA
CTD
PMID:22470460
NCBI chr 8:71,725,405...71,728,729
Ensembl chr 8:71,725,771...71,728,685
G
Sorcs3
sortilin-related VPS10 domain containing receptor 3
decreases expression
ISO
Methylphenidate results in decreased expression of SORCS3 mRNA
CTD
PMID:22470460
NCBI chr 1:267,986,305...268,620,331
Ensembl chr 1:268,189,277...268,620,331
G
Sox11
SRY-box transcription factor 11
increases expression
ISO
Methylphenidate results in increased expression of SOX11 mRNA
CTD
PMID:22470460
NCBI chr 6:46,629,967...46,631,988
Ensembl chr 6:46,629,974...46,631,983
G
Stat5a
signal transducer and activator of transcription 5A
decreases expression
ISO
Methylphenidate results in decreased expression of STAT5A mRNA
CTD
PMID:22470460
NCBI chr10:88,764,732...88,789,060
Ensembl chr10:88,764,732...88,789,057
G
Stox2
storkhead box 2
increases expression
ISO
Methylphenidate results in increased expression of STOX2 mRNA
CTD
PMID:22470460
NCBI chr16:47,994,555...48,233,588
Ensembl chr16:48,120,864...48,228,891
G
Suds3
SDS3 homolog, SIN3A corepressor complex component
decreases expression
ISO
Methylphenidate results in decreased expression of SUDS3 mRNA
CTD
PMID:22470460
NCBI chr12:45,199,012...45,221,507
Ensembl chr12:45,199,577...45,221,512
G
Taar1
trace-amine-associated receptor 1
multiple interactions
ISO
Methylphenidate inhibits the reaction [SLC6A3 protein promotes the reaction [Dopamine results in increased activity of TAAR1 protein]]; Methylphenidate inhibits the reaction [SLC6A3 protein promotes the reaction [Methamphetamine results in increased activity of TAAR1 protein]]; Methylphenidate inhibits the reaction [SLC6A3 protein promotes the reaction [Octopamine results in increased activity of TAAR1 protein]]; Methylphenidate inhibits the reaction [SLC6A3 protein promotes the reaction [tryptamine results in increased activity of TAAR1 protein]]; Methylphenidate inhibits the reaction [SLC6A3 protein promotes the reaction [Tyramine results in increased activity of TAAR1 protein]]
CTD
PMID:17234900
NCBI chr 1:22,595,477...22,596,475
Ensembl chr 1:22,595,477...22,596,475
G
Th
tyrosine hydroxylase
decreases expression
ISO
Methylphenidate results in decreased expression of TH mRNA
CTD
PMID:22470460
NCBI chr 1:216,073,034...216,080,287
Ensembl chr 1:216,073,031...216,080,287
G
Tmem185b
transmembrane protein 185B
decreases expression
ISO
Methylphenidate results in decreased expression of TMEM185B mRNA
CTD
PMID:22470460
NCBI chr13:35,554,621...35,557,952
Ensembl chr13:35,554,964...35,556,016
G
Tmem30a
transmembrane protein 30A
decreases expression
ISO
Methylphenidate results in decreased expression of TMEM30A mRNA
CTD
PMID:22470460
NCBI chr 8:87,222,107...87,245,953
Ensembl chr 8:87,223,948...87,245,951
G
Tnf
tumor necrosis factor
increases expression
ISO
Methylphenidate results in increased expression of TNF mRNA
CTD
PMID:22470460
NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
G
Traf5
TNF receptor-associated factor 5
decreases expression
ISO
Methylphenidate results in decreased expression of TRAF5 mRNA
CTD
PMID:22470460
NCBI chr13:110,758,556...110,801,871
Ensembl chr13:110,758,761...110,784,209
G
Trim25
tripartite motif-containing 25
increases expression
ISO
Methylphenidate results in increased expression of TRIM25 mRNA
CTD
PMID:22470460
NCBI chr10:76,343,847...76,362,159
Ensembl chr10:76,343,847...76,362,145
G
Tspan17
tetraspanin 17
decreases expression
ISO
Methylphenidate results in decreased expression of TSPAN17 mRNA
CTD
PMID:22470460
NCBI chr17:10,356,980...10,364,614
Ensembl chr17:10,356,936...10,364,570
G
Ttf1
transcription termination factor 1
increases expression
ISO
Methylphenidate results in increased expression of TTF1 mRNA
CTD
PMID:22470460
NCBI chr 3:7,635,630...7,660,153
Ensembl chr 3:7,635,933...7,660,673
G
Twsg1
twisted gastrulation BMP signaling modulator 1
decreases expression
ISO
Methylphenidate results in decreased expression of TWSG1 mRNA
CTD
PMID:22470460
NCBI chr 9:113,699,151...113,732,601
Ensembl chr 9:113,699,170...113,732,622
G
Ube3d
ubiquitin protein ligase E3D
decreases expression
ISO
Methylphenidate results in decreased expression of UBE2CBP mRNA
CTD
PMID:22470460
NCBI chr 8:93,948,689...94,120,477
Ensembl chr 8:93,948,767...94,120,458
G
Ubxn10
UBX domain protein 10
decreases expression
ISO
Methylphenidate results in decreased expression of UBXN10 mRNA
CTD
PMID:22470460
NCBI chr 5:157,158,129...157,165,767
Ensembl chr 5:157,159,936...157,165,767
G
Uck2
uridine-cytidine kinase 2
decreases expression
ISO
Methylphenidate results in decreased expression of UCK2 mRNA
CTD
PMID:22470460
NCBI chr13:85,376,716...85,443,976
Ensembl chr13:85,376,716...85,443,976
G
Vash1
vasohibin 1
increases expression
ISO
Methylphenidate results in increased expression of VASH1 mRNA
CTD
PMID:22470460
NCBI chr 6:110,624,377...110,640,942
Ensembl chr 6:110,624,856...110,637,382
G
Wars2
tryptophanyl tRNA synthetase 2 (mitochondrial)
decreases expression
ISO
Methylphenidate results in decreased expression of WARS2 mRNA
CTD
PMID:22470460
NCBI chr 2:201,170,363...201,256,115
Ensembl chr 2:201,172,312...201,255,703
G
Zfp14
ZFP14 zinc finger protein
decreases expression
ISO
Methylphenidate results in decreased expression of ZFP14 mRNA
CTD
PMID:22470460
NCBI chr 1:88,350,361...88,367,370
Ensembl chr 1:88,350,361...88,361,851
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all